Guardant Health grants co-CEOs 465,413 performance-based stock units each at target
GH•Guardant Health granted co-CEOs Helmy Eltoukhy and AmirAli Talasaz 465,413 target performance-based restricted stock units each, with payouts tied to shareholder returns relative to the S&P 500.
1. Awards tied to performance
The awards were granted November 2, 2026, with performance periods beginning June 1, 2026. One-quarter of the units run through May 31, 2029, and the remaining three-quarters through May 31, 2031; target payouts require performance at the 55th percentile relative to the S&P 500, while 250% of target is earned at the 90th percentile.
2. Payout and holding terms
Payouts begin at the 40th percentile, and negative absolute total shareholder returns cap payouts at 100% of target. Vesting generally requires continued service through performance certification; three-year award shares generally face holding restrictions through May 31, 2030, while restrictions apply to half of five-year net after-tax shares through November 30, 2031.
